{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:12:44Z","timestamp":1785114764406,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":2107,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Sydney Cancer Centre"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1037903"],"award-info":[{"award-number":["1037903"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Paul Ainsworth and Dawkins family donations to the Garvan Foundation"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1111\/jth.13612","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T02:07:40Z","timestamp":1483668460000},"page":"477-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin\u20106 dependent"],"prefix":"10.1016","volume":"15","author":[{"given":"C.J.","family":"Reddel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ehteda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.M.Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Curnow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kritharides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13612_bb0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/jth.13612_bb0015","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"key":"10.1111\/jth.13612_bb0020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.thromres.2009.12.023","article-title":"Venous thromboembolism and prognosis in cancer","volume":"125","author":"Khorana","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13612_bb0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10238-013-0230-0","article-title":"Cancer\u2010related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine","volume":"13","author":"Dammacco","year":"2013","journal-title":"Clin Exp Med"},{"key":"10.1111\/jth.13612_bb0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jth.12075","article-title":"Coagulation and cancer: biological and clinical aspects","volume":"11","author":"Falanga","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13612_bb0035","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1182\/blood-2013-04-460147","article-title":"Biomarkers for prediction of venous thromboembolism in cancer","volume":"122","author":"Pabinger","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13612_bb0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3747\/co.21.1864","article-title":"Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management","volume":"21","author":"Donnellan","year":"2014","journal-title":"Curr Oncol"},{"key":"10.1111\/jth.13612_bb0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/bjh.12381","article-title":"Coagulation and metastasis: what does the experimental literature tell us?","volume":"162","author":"Gil\u2010Bernabe","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13612_bb0050","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1182\/blood-2009-10-247296","article-title":"Deadly allies: the fatal interplay between platelets and metastasizing cancer cells","volume":"115","author":"Erpenbeck","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13612_bb0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MOH.0000000000000074","article-title":"Global assays of hemostasis","volume":"21","author":"Brummel\u2010Ziedins","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/jth.13612_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.2009.07833.x","article-title":"Acquired coagulation disorders: revisited using global coagulation\/anticoagulation testing","volume":"147","author":"Tripodi","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13612_bb0065","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.mbc.0000188411.94740.d7","article-title":"Identifying hypocoagulable states with a modified global assay of overall haemostasis potential in plasma","volume":"16","author":"Antovic","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.13612_bb0070","first-page":"2290","article-title":"Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice","volume":"50","author":"Tanaka","year":"1990","journal-title":"Cancer Res"},{"key":"10.1111\/jth.13612_bb0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2407-10-363","article-title":"Molecular, cellular and physiological characterization of the cancer cachexia\u2010inducing C26 colon carcinoma in mouse","volume":"10","author":"Aulino","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1111\/jth.13612_bb0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"key":"10.1111\/jth.13612_bb0085","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1111\/jth.13612_bb0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/JES.0b013e3181f44f11","article-title":"Interleukin 6 as a key regulator of muscle mass during cachexia","volume":"38","author":"Carson","year":"2010","journal-title":"Exerc Sport Sci Rev"},{"key":"10.1111\/jth.13612_bb0095","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer\u2010associated Cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab"},{"key":"10.1111\/jth.13612_bb0100","doi-asserted-by":"crossref","first-page":"e92966","DOI":"10.1371\/journal.pone.0092966","article-title":"Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation","volume":"9","author":"Tsoli","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.13612_bb0105","doi-asserted-by":"crossref","first-page":"e22538","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Bonetto","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.13612_bb0110","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassmann","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13612_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.03061.x","article-title":"Interleukin 6 and haemostasis","volume":"115","author":"Kerr","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13612_bb0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.2910320119","article-title":"Plasminogen activator in normal and tumor\u2010bearing mice","volume":"32","author":"Bruesch","year":"1983","journal-title":"Int J Cancer"},{"key":"10.1111\/jth.13612_bb0125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1111\/jth.13612_bb0130","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.thromres.2010.08.007","article-title":"Monitoring platelet dependent thrombin generation in mice","volume":"126","author":"Dargaud","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13612_bb0135","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1538-7836.2005.01253.x","article-title":"A monoclonal antibody that inhibits mouse tissue factor function","volume":"3","author":"Kirchhofer","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13612_bb0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.thromres.2013.03.015","article-title":"Detection of hypofibrinolysis in stable coronary artery disease using the overall haemostatic potential assay","volume":"131","author":"Reddel","year":"2013","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13612_bb0145","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"key":"10.1111\/jth.13612_bb0150","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat Genet"},{"key":"10.1111\/jth.13612_bb0155","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1538-7836.2009.03448.x","article-title":"Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice","volume":"7","author":"Wang","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13612_bb0160","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1200\/JCO.2010.32.8294","article-title":"Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study","volume":"29","author":"Ay","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1111\/jth.13612_bb0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00007611-199803000-00001","article-title":"The erythrocyte sedimentation rate: old and new clinical applications","volume":"91","author":"Saadeh","year":"1998","journal-title":"South Med J"},{"key":"10.1111\/jth.13612_bb0170","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1182\/blood-2012-06-438598","article-title":"Platelets increase the proliferation of ovarian cancer cells","volume":"120","author":"Cho","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13612_bb0175","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0037-1615947","article-title":"A cell\u2010based model of hemostasis","volume":"85","author":"Hoffman","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13612_bb0180","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1160\/TH12-07-0529","article-title":"Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood","volume":"109","author":"Knappe","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13612_bb0185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.trsl.2008.12.004","article-title":"Regulation of thrombin generation by TFPI in plasma without and with heparin","volume":"153","author":"Brodin","year":"2009","journal-title":"Transl Res"},{"key":"10.1111\/jth.13612_bb0190","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1200\/JCO.2009.22.6324","article-title":"Role of tissue factor in cancer","volume":"27","author":"Kasthuri","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1111\/jth.13612_bb0195","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2011-06-317685","article-title":"The relationship between tissue factor and cancer progression: insights from bench and bedside","volume":"119","author":"van den Berg","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13612_bb0200","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3892\/ol.2013.1437","article-title":"Tissue factor\u2010targeted lidamycin inhibits growth and metastasis of colon carcinoma","volume":"6","author":"Zhang","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1111\/jth.13612_bb0205","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000083835","article-title":"Elevated clotting factor levels and venous thrombosis","volume":"33","author":"Bertina","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1111\/jth.13612_bb0210","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood-2009-05-219915","article-title":"Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology","volume":"114","author":"Cushman","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.13612_bb0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","article-title":"Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI\u20101","volume":"116","author":"Meltzer","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13612_bb0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0038-1642666","article-title":"Thrombin generation in plasma: its assessment via the endogenous thrombin potential","volume":"74","author":"Hemker","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13612_bb0225","first-page":"94","article-title":"Prevention of adenocarcinoma colon 26\u2010induced cachexia by interleukin 10 gene transfer","volume":"57","author":"Fujiki","year":"1997","journal-title":"Cancer Res"},{"key":"10.1111\/jth.13612_bb0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","article-title":"Targeting interleukin\u20106 in inflammatory autoimmune diseases and cancers","volume":"141","author":"Yao","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1111\/jth.13612_bb0235","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1200\/JCO.2012.44.2020","article-title":"Possible role for tocilizumab, an anti\u2010interleukin\u20106 receptor antibody, in treating cancer cachexia","volume":"31","author":"Ando","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1111\/jth.13612_bb0240","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/2326-6066.CIR-14-0022","article-title":"The biology and medical implications of interleukin\u20106","volume":"2","author":"Tanaka","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1111\/jth.13612_bb0245","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13612_bb0250","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin\u20106 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","author":"Hingorani","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/jth.13612_bb0255","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/annrheumdis-2013-204345","article-title":"Effect of interleukin\u20106 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo\u2010controlled study","volume":"74","author":"McInnes","year":"2013","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13612","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622035966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622035966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13612\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:18:29Z","timestamp":1761535109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622035966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1538783622035966"],"URL":"https:\/\/doi.org\/10.1111\/jth.13612","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin\u20106 dependent","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}